CSIMarket Company Name, Ticker, Competitors, else..
 
The Oncology Institute Inc   (NASDAQ: TOI)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

TOI's Market share relative to its competitors, as of Q2 2026

As of Q2 2026 (Revenue in Millions of $)

Date modified: 2026-08-13T09:27:01+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months
Q2 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE
A Quarter Before
Q1 2026
The Oncology Institute Inc 587.24 0.06% 0.07 % 0.06 %
Mckesson Corporation 410,983.00 44.76% 45.81% 36.55%
Cardinal Health Inc 250,735.00 27.31% 26.49% 24.91%
Merck and Co Inc 66,569.00 7.25% 7.22% 6.18%
Pfizer Inc 63,696.00 6.94% 6.54% 5.49%
Astrazeneca Plc 58,739.00 6.40% 6.40% 20.53%
3 more competitors available

Sign in to see all competitors for The Oncology Institute Inc .

Sign In Create Free Account



TOI's Market share relative to its competitors, as of Q2 2026 within the Healthcare Facilities Industry
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE

Q1 2026
The Oncology Institute Inc 89.92% 90.53% 90.74 % 91.81 %
Concord Medical Services Holdings Ltd 10.08% 9.47% 10.08% 9.47%



TOI's Market share relative to its competitors, as of Q2 2026 within the Healthcare Sector
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE

Q1 2026
The Oncology Institute Inc 0.25% 0.23% 0.27 % 0.15 %
Merck and Co Inc 27.87% 29.26% 27.92% 16.88%
Pfizer Inc 26.67% 28.17% 25.28% 14.98%
Astrazeneca Plc 24.59% 20.62% 24.59% 56.06%
Bristol myers Squibb Company 20.59% 21.69% 21.81% 11.91%
Concord Medical Services Holdings Ltd 0.03% 0.02% 0.03% 0.02%



Note: Market share is calculated based on total revenue. To get a more accurate picture of The Oncology Institute Inc's market divisions, geographic dispersion, segments, products, and services, visit The Oncology Institute Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.